Sectors

RMD
ResMed Inc.
204.30
1 x 204.17
1 x 204.62
bid
ask
+
1.84
0.91%
10:13 AM
timesize
Ytd -15.18%
1y -17.81%
203.09
day range
206.00
198.61
52 week range
293.81
Open 204.01 Prev Close 202.46 Low 203.09 High 206.00 Mkt Cap 29.64B
Vol 161.82K Avg Vol 1.14M EPS 10.37 P/E 19.70 Forward P/E 16.65
Beta 0.84 Short Ratio 11.56 Inst. Own 69.14% Dividend 2.40 Div Yield 1.18
Ex Div Date 05-14 Earning 04-30 50-d Avg 223.63 200-d Avg 252.89 1yr Est 270.60
Earning
Date For Estimate Reported Surprise surprise %
2026-04-30 2026-03 2.79 2.86 0.07 2.51%
2026-01-29 2025-12 2.69 2.81 0.12 4.46%
2025-10-30 2025-09 2.49 2.55 0.06 2.41%
2025-07-31 2025-06 2.46 2.55 0.09 3.66%
2025-04-23 2025-03 2.36 2.37 0.01 0.42%
2025-01-30 2024-12 2.3 2.43 0.13 5.65%
Upgrade / Downgrade
Date Firm Action From To
2026-05-01 RBC Capital Upgrade Outperform Outperform
2026-05-01 Wells Fargo Upgrade Equal-Weight Equal-Weight
2026-04-27 Keybanc Upgrade Overweight Overweight
2026-04-09 Citigroup Upgrade Buy Buy
2026-02-02 Citigroup Upgrade Buy Buy
2026-01-30 RBC Capital Upgrade Outperform Outperform
Profile
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Holder
Date Name Relation Quantity Description
2025-11-19 BURT CAROL J Director 18.82K Stock Award(Grant)
2026-05-06 FARRELL MICHAEL J Chief Executive Officer 468.31K Sale
2025-09-07 FARRELL MICHAEL J. Chief Executive Officer 469.88K Sale
2026-03-31 FARRELL PETER CRAIG Director 60.77K Sale
2025-03-09 GHOSHAL KAUSHIK Officer 19.35K Sale
2025-11-19 GILL HARJIT Director 10.94K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 12.09M 2.45B 8.30%
2026-03-30 Vanguard Capital Management LLC 9.47M 1.92B 6.50%
2026-03-30 Vanguard Portfolio Management LLC 7.86M 1.59B 5.40%
2025-12-30 State Street Corporation 6.63M 1.34B 4.55%
2026-03-30 Bank Of New York Mellon Corporation 4.93M 997.96M 3.38%
2025-12-30 Geode Capital Management, LLC 4.30M 871.83M 2.95%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 4.59M 929.42M 3.15%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 3.68M 745.88M 2.53%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 3.18M 643.72M 2.18%
2026-03-30 iShares Trust-iShares Core S&P 500 ETF 1.87M 379.43M 1.29%
2026-03-30 Fidelity Concord Street Trust-Fidelity 500 Index Fund 1.86M 376.95M 1.28%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Growth Index Fund 1.79M 362.74M 1.23%
Dividend
Dividend Date
0.6 2026-05-14
0.6 2026-02-12
0.6 2025-11-13
0.6 2025-08-14
0.53 2025-05-08
0.53 2025-02-13
Split
Split Date
2 : 1 2010-08-31
2 : 1 2005-10-03
2 : 1 2000-04-03
2 : 1 1998-11-17